{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-309334","form_type":"8-K","ticker":"SGMT","cik":"0001400118","company_name":"Sagimet Biosciences Inc.","filed_at":"2026-07-21T01:35:30+00:00","discovered_at":"2026-07-21T10:05:00.249686+00:00","generated_at":"2026-07-21T10:05:24.911931+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Sagimet Biosciences updates investor presentation on metabolic dysfunction therapeutics","bullets":["Company furnished an updated slide deck dated July 2026 for use in investor meetings.","Presentation titled 'Targeting Metabolic Dysfunction with Novel Therapeutics'.","No specific financial or clinical data disclosed in the filing or exhibit.","Update is routine; no material changes to business or guidance provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-309334","json":"https://secwatch.observer/filing/0001193125-26-309334.json","markdown":"https://secwatch.observer/filing/0001193125-26-309334.md","text":"https://secwatch.observer/filing/0001193125-26-309334.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526309334/0001193125-26-309334-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526309334/d141539d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-21T10:05:24.911931+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}